Medication Guide App

Vivaglobin Approved - ZLB Behring - Treatment for Primary Immunodeficiencies

Vivaglobin is a subcutaneous immunoglobulin (Ig) replacement therapy for treating patients with primary immunodeficiencies (PI).

Posted: January 2006

Vivaglobin (immune globulin subcutaneous (human)) FDA Approval History

View comments

Hide
(web3)